Synopsys (NASDAQ:SNPS) Share Price Breaks Below 50 Day Moving Average – Here’s What Happened

Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) shares crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $446.11 and traded as low as $437.37. Synopsys shares last traded at $441.33, with a volume of 1,434,981 shares traded.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. HSBC lowered shares of Synopsys from a “buy” rating to a “reduce” rating in a research report on Friday, September 25th. Mizuho cut their price objective on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating for the company in a report on Thursday, August 27th. UBS Group set a $570.00 price objective on shares of Synopsys in a report on Thursday, August 27th. Needham & Company LLC lifted their price objective on shares of Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a research note on Monday, October 12th. Finally, Weiss Ratings lowered shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and a consensus target price of $575.00.

Read Our Latest Stock Report on Synopsys

Synopsys Price Performance

The business has a fifty day moving average of $446.11 and a 200-day moving average of $440.76. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm has a market cap of $84.58 billion, a PE ratio of 77.97, a PEG ratio of 1.47 and a beta of 1.18.

Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys announced that its Board of Directors has initiated a share repurchase program on Monday, October 5th that permits the company to buy back $1 billion in shares. This repurchase authorization permits the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Insider Activity

In related news, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. This represents a 15.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares in the company, valued at $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 117,163 shares of company stock valued at $51,366,457 over the last ninety days. 0.56% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Synopsys in the second quarter worth $7,228,099,000. Van ECK Associates Corp raised its position in shares of Synopsys by 19.7% in the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock worth $1,542,175,000 after buying an additional 569,687 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock worth $1,377,174,000 after buying an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Synopsys by 11.2% during the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after buying an additional 274,586 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Synopsys during the second quarter valued at $747,400,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Further Reading

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.